Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD

Authors not listed

Shahid Beheshti University of Medical Sciences · 2005

Abstract

To compare the efficacy and safety results of intravitreal bevacizumab alone with bevacizumab + triamcinolone acetonide in neovascular AMD.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-02 MST

Cite this

APA
Anonymous. (2005). Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD. <em>Shahid Beheshti University of Medical Sciences</em>. https://clinicaltrials.gov/study/NCT00370370
Vancouver
Anonymous. Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD. Shahid Beheshti University of Medical Sciences. 2005.
BibTeX
@misc{anon2005Intrav, title = {Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMD}, author = {Anonymous}, journal = {Shahid Beheshti University of Medical Sciences}, year = {2005}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings